Related Links Educational Materials About Clinical Trials Clinical Trials Questions to Ask Your Doctor Drug Information from MedlinePlus

Alternate Title
Basic Trial Information
Trial Description
     Purpose
     Eligibility
     Treatment/Intervention
Trial Contact Information
Registry Information

Alternate Title

Phase I Study of Sodium Salicylate in Patients With Advanced Myelodysplastic Syndrome; Newly Diagnosed, Relapsed, or Refractory Acute Myelogenous Leukemia; or Relapsed or Refractory Chronic Lymphocytic Leukemia

Basic Trial Information

Phase	Type	Status	Age	Sponsor	Protocol IDs
Phase I	Treatment	Closed	Over 18	NCI	MSKCC-99057 NCI-G99-1661, NCT00004245

Trial Description

Purpose:

Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die.

Phase I trial to study the effectiveness of sodium salicylate in treating patients who have advanced myelodysplastic syndrome, acute myelogenous leukemia or chronic lymphocytic leukemia.

Eligibility:

• At least 19 years old
• For more information about the eligibility criteria for this trial, refer to the Health Professional version.

Final eligibility for a clinical trial is determined by the health professionals conducting the trial.

Treatment/Intervention:

Patients will receive sodium salicylate by mouth twice a day for up to six weeks. Some patients may receive treatment beyond the 6-week period. Patients will receive follow-up evaluations.

Important:

For more details about this trial, refer to the Health Professional version of the trial summary.

If you are interested in participating in a clinical trial, contact your doctor for a referral or call a trial contact person listed below. You may see the same contact person listed at more than one site, however, if you call the number listed you can ask to speak to the study coordinator or person involved with the specific trial you are interested in. If you have questions about cancer or clinical trials, call the Cancer Information Service at 1-800-4-CANCER (1-800-422-6237). General information about clinical trials, including risks, benefits, and costs, can be found on NCI's Web site.

Trial Contact Information

Trial Lead Organizations

Memorial Sloan-Kettering Cancer Center

Virginia Klimek, MD, Protocol chair		Ph: 212-639-6519; 800-525-2225

Registry Information
Official Title		A Phase I Study of Salicylate for Adult Patients with Advanced Myelodysplastic Disorders or Acute Myelogenous Leukemia
Trial Start Date		1999-08-24
Registered in ClinicalTrials.gov		NCT00004245
Date Submitted to PDQ		1999-12-27
Information Last Verified		2004-12-14
NCI Grant/Contract Number		P30-CA08748

Back to Top